These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22919984)

  • 21. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dispensing pattern of generic and brand-name drugs in children.
    Chen AY; Wu S
    Ambul Pediatr; 2008; 8(3):189-94. PubMed ID: 18501866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital.
    Patel GW; Duquaine SM; McKinnon PS
    Pharmacotherapy; 2007 Dec; 27(12):1637-43. PubMed ID: 18041884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Meropenem as empirical therapy in moderate to severe infections in hospitalized children aged 3 to 12 months and 1 to 14 years].
    Pérez-Gorricho B; Zapardiel Ferrero J;
    Rev Esp Quimioter; 2004 Dec; 17(4):341-9. PubMed ID: 15696225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care.
    Edwards SJ; Campbell HE; Plumb JM
    Eur J Health Econ; 2006 Mar; 7(1):72-8. PubMed ID: 16429296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors.
    Düzova A; Kutluk T; Kanra G; Büyükpamukçu M; Akyüz C; Seçmeer G; Ceyhan M
    Turk J Pediatr; 2001; 43(2):105-9. PubMed ID: 11432485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Childhood asthma: proper managements do reduce severity.
    Vangveeravong M
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S648-55. PubMed ID: 14700162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, safety and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patients.
    Bradley JS; Faulkner KL; Klaugman KP
    Pediatr Infect Dis J; 1996 Aug; 15(8):749-57. PubMed ID: 8858694
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical pharmacology and indications of meropenem in severe pediatric infection].
    Honorato J; Sádaba B; Díaz M
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():38-44. PubMed ID: 9410068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.
    Orenstein SR; Gremse DA; Pantaleon CD; Kling DF; Rotenberg KS
    Clin Ther; 2005 Apr; 27(4):472-83. PubMed ID: 15922820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generic antibiotic drugs: is effectiveness guaranteed?
    Gauzit R; Lakdhari M
    Med Mal Infect; 2012 Apr; 42(4):141-8. PubMed ID: 22480963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
    Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
    Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins.
    Atanasković-Marković M; Gaeta F; Medjo B; Viola M; Nestorović B; Romano A
    Allergy; 2008 Feb; 63(2):237-40. PubMed ID: 18186815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit.
    Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J
    Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model.
    Scheetz MH; Bolon MK; Esterly JS; Reddy P; Postelnick M; Lee TA
    Pharmacotherapy; 2011 May; 31(5):469-79. PubMed ID: 21923428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
    Tsai YS; Lan SK; Ou JH; Tzai TS
    Clin Ther; 2007 Apr; 29(4):670-82. PubMed ID: 17617290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the appropriate use of meropenem for the treatment of serious bacterial infections.
    Kollef MH
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S1-2. PubMed ID: 18713044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.